Sleep ap­nea biotech breathes easy with $62.5M fi­nanc­ing ahead of PhI­II tri­als for lead oral drug

Tra­di­tion­al care for ob­struc­tive sleep ap­nea in­volves CPAP, a cum­ber­some coun­ter­mea­sure in which pa­tients have air con­tin­u­ous­ly pushed through a mask they have to wear …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER